iRhythm Technologies (IRTC) Expected to Announce Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC) is projected to announce its Q4 2025 results after the market closes on Thursday, February 19th. Analysts expect the company to announce earnings of $0.02 per share and revenue of $202.6060 million for the quarter. Interested persons can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Thursday, February 19, 2026 at 4:30 PM ET.

iRhythm Technologies Stock Performance

Shares of iRhythm Technologies stock opened at $152.11 on Thursday. The company has a debt-to-equity ratio of 5.32, a current ratio of 4.63 and a quick ratio of 4.50. The stock has a market cap of $4.90 billion, a price-to-earnings ratio of -94.48 and a beta of 1.06. iRhythm Technologies has a 1 year low of $92.52 and a 1 year high of $212.00. The firm’s 50-day moving average is $168.02 and its 200 day moving average is $171.34.

Analysts Set New Price Targets

IRTC has been the subject of several analyst reports. Evercore raised shares of iRhythm Technologies from an “in-line” rating to an “outperform” rating and raised their price target for the company from $194.00 to $210.00 in a research report on Monday, January 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of iRhythm Technologies in a research report on Thursday, January 22nd. Wells Fargo & Company boosted their price target on iRhythm Technologies from $220.00 to $225.00 and gave the stock an “overweight” rating in a report on Tuesday, January 13th. Citigroup boosted their price target on shares of iRhythm Technologies from $205.00 to $242.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Finally, BTIG Research upped their price objective on iRhythm Technologies from $195.00 to $215.00 and gave the stock a “buy” rating in a research report on Friday, October 31st. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $219.23.

Insiders Place Their Bets

In other iRhythm Technologies news, insider Patrick Michael Murphy sold 2,478 shares of iRhythm Technologies stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $184.83, for a total value of $458,008.74. Following the transaction, the insider directly owned 53,281 shares of the company’s stock, valued at $9,847,927.23. The trade was a 4.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Chad Patterson sold 280 shares of the business’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $184.83, for a total transaction of $51,752.40. Following the transaction, the insider directly owned 43,387 shares in the company, valued at $8,019,219.21. This trade represents a 0.64% decrease in their position. The disclosure for this sale is available in the SEC filing. 1.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On iRhythm Technologies

Several institutional investors and hedge funds have recently bought and sold shares of IRTC. US Bancorp DE increased its stake in iRhythm Technologies by 7.8% in the third quarter. US Bancorp DE now owns 1,042 shares of the company’s stock valued at $179,000 after acquiring an additional 75 shares during the period. State of Wyoming boosted its holdings in shares of iRhythm Technologies by 16.0% in the 4th quarter. State of Wyoming now owns 616 shares of the company’s stock worth $109,000 after acquiring an additional 85 shares in the last quarter. Alliancebernstein L.P. boosted its stake in iRhythm Technologies by 0.3% in the third quarter. Alliancebernstein L.P. now owns 37,489 shares of the company’s stock worth $6,448,000 after purchasing an additional 95 shares in the last quarter. California State Teachers Retirement System raised its holdings in shares of iRhythm Technologies by 0.3% in the second quarter. California State Teachers Retirement System now owns 28,917 shares of the company’s stock valued at $4,452,000 after buying an additional 99 shares during the last quarter. Finally, Vident Advisory LLC increased its position in iRhythm Technologies by 6.1% in the 3rd quarter. Vident Advisory LLC now owns 2,442 shares of the company’s stock valued at $420,000 after acquiring an additional 141 shares in the last quarter.

iRhythm Technologies Company Profile

iRhythm Technologies, Inc is a medical technology company that develops and commercializes wearable cardiac monitoring devices and associated data analytics services. Founded in 2006 and headquartered in San Francisco, California, the company’s flagship product is the Zio® patch, a discreet, single-use, continuous ECG recorder designed to monitor heart rhythms for up to 14 days. iRhythm’s digital diagnostics platform combines biosensor technology with proprietary algorithms to detect arrhythmias and streamline data interpretation for physicians.

The Zio service is prescribed by cardiologists and other healthcare providers to aid in the diagnosis of atrial fibrillation, bradycardia, tachycardia and other rhythm disorders.